FDA Monthly Preview: Key April Decisions to Watch - Top-Institutions - MDSpire

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.

  • By

  • Kathryn Wighton

  • March 31, 2026

  • 3 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Nephrology
    • Endocrinology
    • Infectious Diseases

  • #2

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Infectious Diseases
    • Endocrinology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Nephrology
    • Endocrinology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Infectious Diseases
    • Endocrinology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Nephrology
    • Endocrinology
    • Infectious Diseases

Original Source(s)

FDA Monthly Preview: Key April Decisions to Watch

  • by Kathryn Wighton

  • March 31, 2026

Related Content

Diet-Dementia Link Varies by Biomarkers

Effects varied by which biomarker and diet were measured, and the study stops short of proving diet changes risk.

Mass Spec Roundup: Ubiquitin, Pollutants, and Pain

Non-protein ubiquitination, cryogenic chemical mapping, wastewater antidepressants, and new molecular clues to post-stroke pain

  • June 10, 2026

  • 6 min
Acupuncture for Neuroinfections?

A recent Perspective offered a speculative mechanistic argument for acupuncture’s potential role as an adjunctive strategy in neuroinfectious diseases.